RXO Inc.
RXO | NYSE
$20.18
+$0.46 (+2.33%)
Sep 22, 2026, 9:47 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.09B | 5.73B | 5.74B | 5.94B | 5.56B | 5.07B | 4.55B | 3.86B | 3.8B | 3.83B | 3.93B | 4.07B | 4.23B | 4.49B | 4.8B | 5B | 5.06B | 4.94B | 4.69B | 3.36B | 2.16B | 1.07B |
Cost of Revenue | 3.56B | 4.75B | 4.76B | 4.99B | 4.66B | 4.23B | 3.8B | 3.19B | 3.14B | 3.17B | 3.24B | 3.36B | 3.5B | 3.68B | 3.94B | 4.13B | 4.2B | 4.1B | 3.86B | 2.75B | 1.74B | 859M |
Gross Profit | 2.53B | 981M | 985M | 952M | 898M | 837M | 750M | 669M | 662M | 662M | 689M | 708M | 735M | 817M | 860M | 870M | 860M | 834M | 825M | 617M | 425M | 206M |
Operating Income | -35M | -26M | -37M | -51M | -64M | -65M | -47M | -9M | 17M | 22M | 39M | 24M | 33M | 77M | 123M | 179M | 202M | 191M | 192M | 137M | 99M | 52M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 1M | 1M | 1M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -123M | -125M | -115M | -97M | -324M | -322M | -304M | -267M | -28M | -14M | 4M | -6M | 12M | 65M | 119M | 180M | 203M | 192M | 191M | 136M | 98M | 50M |
Net Income | -105M | -105M | -100M | -79M | -308M | -306M | -290M | -263M | -21M | -11M | 4M | -2M | 12M | 53M | 92M | 138M | 158M | 149M | 150M | 108M | 75M | 40M |
Selling & General & Admin | 397K | 397K | 200K | n/a | n/a | n/a | 145M | 145M | 145M | 289M | 297M | 452M | 610M | 632M | 640M | 637M | 479M | 485M | 324M | 172M | 172M | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 2.57B | 1.01B | 1.02B | 1B | 962M | 902M | 652M | 533M | 500M | 351M | 353M | 232M | 92M | 108M | 97M | 54M | 179M | 158M | 309M | 308M | 154M | 154M |
Operating Expenses | 2.57B | 1.01B | 1.02B | 1B | 962M | 902M | 797M | 678M | 645M | 640M | 650M | 684M | 702M | 740M | 737M | 691M | 658M | 643M | 633M | 480M | 326M | 154M |
Interest Expense | 27.01M | 26.01M | 35M | 34M | 31M | 31M | 30M | 30M | 32M | 32M | 32M | 29M | 21M | 13M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 144M | 297M | 452M | 610M | 632M | 640M | 637M | 479M | 313M | 152M | n/a | n/a | n/a |
Cost & Expenses | 6.12B | 5.76B | 5.78B | 5.99B | 5.62B | 5.14B | 4.6B | 3.87B | 3.78B | 3.81B | 3.89B | 4.05B | 4.2B | 4.42B | 4.67B | 4.82B | 4.86B | 4.75B | 4.5B | 3.23B | 2.07B | 1.01B |
Income Tax Expense | -18M | -20M | -15M | -18M | -16M | -16M | -14M | -4M | -7M | -3M | n/a | -4M | n/a | 12M | 27M | 42M | 45M | 43M | 41M | 28M | 23M | 10M |
Shares Outstanding (Basic) | 169.65M | 169.1M | 168.72M | 168.58M | 168.53M | 168.02M | 164.41M | 134.1M | 117.58M | 117.22M | 117.01M | 116.97M | 116.89M | 116.6M | 116.4M | 115.11M | 115.11M | 115.11M | 115.11M | 115M | 115.11M | 116.4M |
Shares Outstanding (Diluted) | 169.65M | 169.1M | 168.72M | 168.58M | 168.53M | 168.02M | 164.41M | 134.1M | 117.58M | 117.22M | 119.58M | 116.97M | 119.46M | 119.37M | 116.4M | 115.11M | 115.11M | 115.11M | 115.11M | 115.11M | 115.11M | 116.4M |
EPS (Basic) | -0.61 | -0.62 | -0.59 | -0.47 | -2.19 | -2.20 | -2.15 | -1.98 | -0.18 | -0.10 | 0.03 | -0.02 | 0.10 | 0.46 | 0.80 | 1.19 | 1.37 | 1.29 | 1.29 | 0.93 | 0.64 | 0.34 |
EPS (Diluted) | -0.61 | -0.62 | -0.59 | -0.47 | -2.19 | -2.20 | -2.15 | -1.98 | -0.18 | -0.10 | 0.03 | -0.02 | 0.10 | 0.46 | 0.80 | 1.19 | 1.37 | 1.29 | 1.29 | 0.93 | 0.64 | 0.34 |
EBITDA | 31.01M | -20.99M | 24M | 112M | 125M | 114M | 95M | 86M | 80M | 100M | 120M | 54M | 94M | 137M | 189M | 297M | 292M | 280M | 278M | 203M | 141M | 73M |
EBIT | -127.99M | -130.99M | -92M | -9M | 9M | 11M | 8M | 17M | 16M | 35M | 53M | -19M | 14M | 54M | 103M | 213M | 209M | 198M | 197M | 141M | 101M | 53M |
Depreciation & Amortization | 159M | 110M | 116M | 121M | 116M | 103M | 87M | 69M | 64M | 65M | 67M | 73M | 80M | 83M | 86M | 84M | 83M | 82M | 81M | 62M | 40M | 20M |
Add to Watchlist
Select watchlists to add or remove RXO